FDA Rejects Lundbeck and Otsuka's Rexulti for PTSD on Insufficient Efficacy Evidence on September 23, 2025 brexpiprazole Clinical Trials Complete Drug Approval Lundbeck Otsuka Post-Traumatic Stress Disorder Response Letter Rexulti sertraline sNDA United States Food and Drug Administration +
FDA Advisory Committee Rejects Lundbeck and Otsuka's PTSD Bid for Rexulti on July 21, 2025 Advisory Committees brexpiprazole Clinical Trials drug efficacy Lundbeck Otsuka Post-Traumatic Stress Disorder Rexulti sertraline United States Food and Drug Administration +